In recent years, cancer treatments have become increasingly sophisticated, precise and, in some cases, less invasive. But a new system being developed by researchers at The University of Texas at Austin could herald an even more significant advance in the fight against cancer.
The system, which is based on a technology called photodynamic therapy, involves using light to trigger a chemical reaction that kills cancer cells. What makes this approach potentially game-changing is that it can be targeted to very specific areas of the body, minimising the side effects that are often associated with more traditional cancer treatments such as surgery and radiotherapy.
The system is still in the early stages of development, but the team behind it is confident that it could one day be used to treat a wide range of cancers with minimal invasiveness. The hope is that the treatment will be particularly effective against hard-to-treat cancers that have spread to multiple parts of the body.
The next step is to conduct clinical trials to assess the safety and effectiveness of the system. If all goes well, this could be a major breakthrough in cancer treatment.
A new cancer treatment system that uses light to activate drugs has shown success in early clinical trials.
The system, which is called CESTAT, uses Tunable VUV light to photoactivate cancer drugs. The light is tuned to a specific wavelength that is absorbed by the cancer cells, causing the drug to be activated.
The system has been tested in a small number of patients with advanced cancer, and has shown promise in treating the disease. The trial is ongoing, and the system is not yet approved for use in the United States.
CESTAT is a potentially groundbreaking new treatment for cancer, and could provide a more effective and less toxic option for patients with the disease.